295 related articles for article (PubMed ID: 24501330)
1. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.
Bucci M; Vellecco V; Cantalupo A; Brancaleone V; Zhou Z; Evangelista S; Calderone V; Papapetropoulos A; Cirino G
Cardiovasc Res; 2014 Apr; 102(1):138-47. PubMed ID: 24501330
[TBL] [Abstract][Full Text] [Related]
2. H
Monti M; Terzuoli E; Ziche M; Morbidelli L
Pharmacol Res; 2016 Nov; 113(Pt A):426-437. PubMed ID: 27650753
[TBL] [Abstract][Full Text] [Related]
3. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Macabrey D; Deslarzes-Dubuis C; Longchamp A; Lambelet M; Ozaki CK; Corpataux JM; Allagnat F; Déglise S
Eur J Vasc Endovasc Surg; 2022 Feb; 63(2):336-346. PubMed ID: 34916111
[TBL] [Abstract][Full Text] [Related]
5. Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability.
Terzuoli E; Monti M; Vellecco V; Bucci M; Cirino G; Ziche M; Morbidelli L
Br J Pharmacol; 2015 Jun; 172(12):2961-73. PubMed ID: 25631232
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.
Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA
Br J Pharmacol; 2009 Dec; 158(8):1911-21. PubMed ID: 19917062
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of CSE and CBS in the corpus cavernosum of spontaneous hypertensive rats].
Zhu XB; Jiang J; Jiang R; Chen F
Zhonghua Nan Ke Xue; 2014 Jan; 20(1):4-9. PubMed ID: 24527529
[TBL] [Abstract][Full Text] [Related]
9. [Changes and significance of hydrogen sulfide/cystathionine gamma-lyase system in hypertension: an experimental study with rats].
Yan H; Du JB; Tang CS
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1114-7. PubMed ID: 15312517
[TBL] [Abstract][Full Text] [Related]
10. Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats.
Zhao X; Zhang LK; Zhang CY; Zeng XJ; Yan H; Jin HF; Tang CS; DU JB
Hypertens Res; 2008 Aug; 31(8):1619-30. PubMed ID: 18971538
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide is involved in dexamethasone-induced hypertension in rat.
d'Emmanuele di Villa Bianca R; Mitidieri E; Donnarumma E; Tramontano T; Brancaleone V; Cirino G; Bucci M; Sorrentino R
Nitric Oxide; 2015 Apr; 46():80-6. PubMed ID: 25461303
[TBL] [Abstract][Full Text] [Related]
12. The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760.
Cacanyiova S; Cebova M; Simko F; Baka T; Bernatova I; Kluknavsky M; Zorad S; Krskova K; Shaman E; Zemancikova A; Barta A; Aydemir BG; Berenyiova A
Biol Res; 2023 Oct; 56(1):55. PubMed ID: 37875978
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Giusti A; Uhr MR
Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
Sargent CA; Sleph PG; Dzwonczyk S; Smith MA; Normandin D; Antonaccio MJ; Grover GJ
J Pharmacol Exp Ther; 1993 May; 265(2):609-18. PubMed ID: 8496812
[TBL] [Abstract][Full Text] [Related]
16. Endogenous Hydrogen Sulfide Enhances Carotid Sinus Baroreceptor Sensitivity by Activating the Transient Receptor Potential Cation Channel Subfamily V Member 1 (TRPV1) Channel.
Yu W; Liao Y; Huang Y; Chen SY; Sun Y; Sun C; Wu Y; Tang C; Du J; Jin H
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512115
[TBL] [Abstract][Full Text] [Related]
17. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH
Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693
[TBL] [Abstract][Full Text] [Related]
18. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
19. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
[TBL] [Abstract][Full Text] [Related]
20. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA
J Pharm Pharmacol; 2016 Nov; 68(11):1422-1429. PubMed ID: 27670145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
